AMAL vs. IPSC

Last updated Apr 1, 2026

Compare and contrast key facts about Amalgamated Financial Corp. (AMAL) and Century Therapeutics, Inc. (IPSC).

Performance

AMAL vs. IPSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amalgamated Financial Corp. (AMAL) and Century Therapeutics, Inc. (IPSC). The values are adjusted to include any dividend payments, if applicable.

AMAL vs. IPSC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
AMAL Amalgamated Financial Corp.	21.87%	-2.50%	26.32%	19.44%	39.78%	9.80%
IPSC Century Therapeutics, Inc.	127.18%	-1.50%	-69.58%	-35.28%	-67.65%	-30.53%

Fundamentals

Market Cap AMAL : $1.18B IPSC : $195.62M
EPS AMAL : $3.43 IPSC : -$0.11
PS Ratio AMAL : 2.60 IPSC : 1.79
PB Ratio AMAL : 1.48 IPSC : 1.23
Total Revenue (TTM) AMAL : $455.03M IPSC : $109.16M
Gross Profit (TTM) AMAL : $319.80M IPSC : $102.83M
EBITDA (TTM) AMAL : $144.97M IPSC : -$3.89M

Returns By Period

In the year-to-date period, AMAL achieves a 21.87% return, which is significantly lower than IPSC's 127.18% return.

AMAL

• 1D: 1.65%
• 1M: 0.99%
• YTD: 21.87%
• 6M: 44.51%
• 1Y: 37.79%
• 3Y*: 32.47%
• 5Y*: 20.13%
• 10Y*: —

IPSC

• 1D: 11.33%
• 1M: -2.59%
• YTD: 127.18%
• 6M: 353.82%
• 1Y: 374.79%
• 3Y*: -13.32%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

AMAL vs. IPSC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMAL

AMAL Risk / Return Rank: 74
AMAL Sharpe Ratio Rank: 79
AMAL Sortino Ratio Rank: 74
AMAL Omega Ratio Rank: 71
AMAL Calmar Ratio Rank: 73
AMAL Martin Ratio Rank: 72

IPSC

IPSC Risk / Return Rank: 97
IPSC Sharpe Ratio Rank: 98
IPSC Sortino Ratio Rank: 97
IPSC Omega Ratio Rank: 95
IPSC Calmar Ratio Rank: 98
IPSC Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMAL vs. IPSC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amalgamated Financial Corp. (AMAL) and Century Therapeutics, Inc. (IPSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AMAL	IPSC	Difference
Sharpe ratio Return per unit of total volatility	1.19	3.79	-2.60
Sortino ratio Return per unit of downside risk	1.77	4.07	-2.30
Omega ratio Gain probability vs. loss probability	1.22	1.49	-0.27
Calmar ratio Return relative to maximum drawdown	1.56	9.21	-7.65
Martin ratio Return relative to average drawdown	3.64	20.71	-17.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AMAL vs. IPSC - Sharpe Ratio Comparison

The current AMAL Sharpe Ratio is 1.19, which is lower than the IPSC Sharpe Ratio of 3.79. The chart below compares the historical Sharpe Ratios of AMAL and IPSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	AMAL	IPSC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.19	3.79	-2.60
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.60	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.35	-0.45	+0.80

Correlation

The correlation between AMAL and IPSC is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

AMAL vs. IPSC - Dividend Comparison

AMAL's dividend yield for the trailing twelve months is around 1.52%, while IPSC has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018
AMAL Amalgamated Financial Corp.	1.52%	1.75%	1.37%	1.48%	1.56%	1.91%	2.33%	1.34%	0.31%
IPSC Century Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

AMAL vs. IPSC - Drawdown Comparison

The maximum AMAL drawdown since its inception was -62.93%, smaller than the maximum IPSC drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for AMAL and IPSC.

Drawdown Indicators

	AMAL	IPSC	Difference
Max Drawdown Largest peak-to-trough decline	-62.93%	-98.78%	+35.85%
Max Drawdown (1Y) Largest decline over 1 year	-24.41%	-36.98%	+12.57%
Max Drawdown (5Y) Largest decline over 5 years	-46.88%	—	—
Current Drawdown Current decline from peak	-7.25%	-92.92%	+85.67%
Average Drawdown Average peak-to-trough decline	-20.34%	-80.03%	+59.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.45%	16.45%	-6.00%

Volatility

AMAL vs. IPSC - Volatility Comparison

The current volatility for Amalgamated Financial Corp. (AMAL) is 5.58%, while Century Therapeutics, Inc. (IPSC) has a volatility of 28.21%. This indicates that AMAL experiences smaller price fluctuations and is considered to be less risky than IPSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AMAL	IPSC	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.58%	28.21%	-22.63%
Volatility (6M) Calculated over the trailing 6-month period	22.47%	81.70%	-59.23%
Volatility (1Y) Calculated over the trailing 1-year period	31.92%	99.88%	-67.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.82%	84.63%	-50.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.24%	84.63%	-44.39%

Financials